Bayer Q310 Results Exceed Market Expectations

BMI View: BMI was not surprised to see Bayer?s Q310 financial results exceed consensus forecasts. Bayer?s diverse portfolio of services and its high exposure to the emerging markets make it well placed for growth in the short, medium and long term. The company?s short-term growth will be driven by its Material Science and Crop Science divisions as poor sales in Europe and the US continue to limit its growth in the healthcare sector. High growth in emerging markets will become the key driver of healthcare sales.

To read the full article, please choose one of the following options: